Skip to search formSkip to main contentSkip to account menu

NU-ICRF 505

Known as: ICRF 505, NU 505, NU-ICRF-505 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

AnthraquinonesTyrosine
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1997
1997
Cell cycle effects of the novel topoisomerase I inhibitor NU/ICRF 505 in a panel of Chinese hamster ovary cell lines.
1996
1996
Characterization of the major metabolite of the novel topoisomerase I inhibitor NU/ICRF 505.
NU/ICRF 505 is a tyrosine conjugate of anthraquinone modified at the C terminus of the amino acid as an ethyl ester and it… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)